FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Nephron Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Ketorolac tromethamine filed by Nephron Pharmaceuticals Corporation under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)